查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1596676

脊椎器械和生技药品市场：按类型、按应用分类 - 2025-2030 年全球预测

Spinal Devices & Biologics Market by Type (Fracture Treatment, Motion Preservation, Non-Fusion Technologies), Application (Ambulatory Surgical Centers, Clinics, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年脊椎器械和生技药品市值为97.6亿美元，预计2024年将达到113.8亿美元，2030年将增加至287.8亿美元，预计复合年增长率为16.70%。

脊椎设备和生技药品市场包括用于治疗脊椎疾病的各种医疗保健产品，例如脊椎移植、设备和生物材料。这些产品有助于涉及退化性疾病、创伤和先天畸形的脊椎手术、修復和再生。脊椎疾病盛行率上升、人口老化以及对微创手术的日益偏好推动了对这些产品的需求。适用范围广泛，涵盖退化性疾病、复杂畸形、肿瘤、创伤、慢性脊椎疼痛等病症。典型的最终用户包括医院、整形外科诊所和门诊手术中心，其专家包括从骨科医生到神经外科医生等。

主要市场统计
基准年[2023] 97.6亿美元
预测年份 [2024] 113.8亿美元
预测年份 [2030] 287.8亿美元
复合年增长率（%） 16.70%

脊椎器械的技术进步、对改善手术结果的需求增加以及更快的恢復时间推动了成长。然而，该市场也面临严格的监管要求、先进设备的高成本以及可能导致再次手术的术后併发症等挑战。机会在于下一代微创设备的开发、3D 列印技术在製造中的日益集成，以及干细胞疗法和生长因子等生技药品增强脊椎融合和再生的潜力。因此，投资于支持加速癒合和融合的生物材料研究是一个成熟的创新领域。

儘管预计将出现显着成长，但市场受到高研发成本、报销问题以及产品召回和故障可能性的限制。寻求成长的公司应专注于降低製造成本的创新，确保更安全、更有效的结果，并更有效地通过法律规范。我们专注于个人化脊椎护理解决方案、检验新技术的稳健临床试验以及技术转移伙伴关係，有助于降低市场风险并提高竞争力。市场仍然充满活力并由科学主导，支持持续的研究和开发，以实现永续增长并在脊髓治疗的进步中发挥领导作用。

市场动态：揭示快速发展的脊椎器材和生技药品市场的关键市场洞察

供需的动态交互作用正在改变脊椎器械和生技药品市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 退化性脊椎疾病盛行率增加
    • 微创脊椎手术需求激增
    • 脊椎生技药品技术不断进步
  • 市场限制因素
    • 产品召回问题
  • 市场机会
    • 脊椎移植和设备的需求不断增长
    • 扩增实境、内视镜手术以及改进脊椎手术的 3D 列印植入
  • 市场挑战
    • 报销政策的缺点和模糊性

波特的五力：驾驭脊椎器械和生技药品市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解脊椎设备和生技药品市场的外部影响

外部宏观环境因素在塑造脊椎器械和生技药品市场的绩效动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解脊椎器材和生技药品市场的竞争格局

脊椎设备和生技药品市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵脊椎器械和生技药品市场供应商的绩效评估

FPNV 定位矩阵是评估脊椎设备和生技药品市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了脊椎器械和生技药品市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对脊椎器械和生技药品市场进行策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 退化性脊椎疾病盛行率增加
      • 微创脊椎手术需求快速成长
      • 脊椎生物製药技术进步
    • 抑制因素
      • 产品召回问题
    • 机会
      • 脊椎移植和设备的需求增加
      • 扩增实境和虚拟实境、内视镜手术以及改进的用于脊椎手术的 3D 列印植入
    • 任务
      • 退款政策的缺点和模糊性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章脊柱器械和生技药品市场：按类型

  • 骨折治疗
  • 动作储存
  • 非融合技术
  • 脊椎融合手术

第七章脊椎器械和生技药品市场：依应用分类

  • 门诊手术中心
  • 诊所
  • 医院

第八章美洲脊柱器械和生技药品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区脊椎器械和生技药品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的脊椎器材和生技药品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Acuity Surgical Devices, LLC
  • Aesculap Implant Systems, LLC
  • DJO, LLC
  • Exactech, Inc.
  • Innovasis, Inc.
  • Integra LifeSciences Holdings Corporation
  • Invictus Medical LLC
  • Kohlberg & Company, LLC
  • Medtronic PLC
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Wright Medical Group NV
  • Ossur Group
Product Code: MRR-710B1F0AC641

The Spinal Devices & Biologics Market was valued at USD 9.76 billion in 2023, expected to reach USD 11.38 billion in 2024, and is projected to grow at a CAGR of 16.70%, to USD 28.78 billion by 2030.

The spinal devices and biologics market encompasses a wide range of healthcare products used in the treatment of spinal disorders, including spinal implants, devices, and biologic materials. These products facilitate spinal surgeries, repairs, and regeneration where degenerative conditions, trauma, or congenital deformities are involved. Their necessity stems from the rising prevalence of spinal disorders, an aging population, and an increasing preference for minimally invasive surgical procedures. The application range is vast, covering conditions such as degenerative disc disease, complex deformities, tumors, trauma cases, and chronic spine pain. Primary end-users include hospitals, orthopedic clinics, and ambulatory surgical centers, with specialists ranging from orthopedic surgeons to neurosurgeons.

KEY MARKET STATISTICS
Base Year [2023] USD 9.76 billion
Estimated Year [2024] USD 11.38 billion
Forecast Year [2030] USD 28.78 billion
CAGR (%) 16.70%

Growth is influenced by technological advancements in spinal devices, enhanced surgical outcomes, and a growing demand for reduced recovery times. However, this market also faces challenges such as stringent regulatory requirements, high costs of advanced devices, and potential post-surgical complications leading to revised interventions. Opportunities lie in the development of next-generation minimally invasive devices, increased integration of 3D printing technology in manufacturing, and the potential of biologics, such as stem cell therapies and growth factors, in enhancing spinal fusion and regeneration. Therefore, investing in research on biomaterials that support enhanced healing and fusion processes represents an area ripe for innovation.

Despite strong growth prospects, the market is limited by high research and development costs, reimbursement issues, and potential product recalls or malfunctions. Companies aiming for growth should focus on innovations that lower production costs, ensure safer and more effective outcomes, and navigate regulatory frameworks efficiently. Emphasis on personalized spinal care solutions, robust clinical trials validating new technologies, and partnerships for technology transfers can mitigate market risks and enhance competitiveness. The market remains dynamic and science-driven, favoring continual research and development for sustainable growth and leadership in spinal care advancements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Spinal Devices & Biologics Market

The Spinal Devices & Biologics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of degenerative spine disorders
    • Surging demand for minimally invasive spine surgery
    • Growing technological advancements in spine biologics
  • Market Restraints
    • Issues related to product recalls
  • Market Opportunities
    • Rising demand for spinal implants and devices
    • Improvement in augmented & virtual reality, endoscopic surgery, and 3D printed implants for spine surgery
  • Market Challenges
    • Unfavorable and ambiguity in reimbursement policies

Porter's Five Forces: A Strategic Tool for Navigating the Spinal Devices & Biologics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Spinal Devices & Biologics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Spinal Devices & Biologics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Spinal Devices & Biologics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Spinal Devices & Biologics Market

A detailed market share analysis in the Spinal Devices & Biologics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Spinal Devices & Biologics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Spinal Devices & Biologics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Spinal Devices & Biologics Market

A strategic analysis of the Spinal Devices & Biologics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Spinal Devices & Biologics Market, highlighting leading vendors and their innovative profiles. These include Acuity Surgical Devices, LLC, Aesculap Implant Systems, LLC, DJO, LLC, Exactech, Inc., Innovasis, Inc., Integra LifeSciences Holdings Corporation, Invictus Medical LLC, Kohlberg & Company, LLC, Medtronic PLC, NuVasive, Inc., Orthofix Medical Inc., Smith & Nephew PLC, Stryker Corporation, Wright Medical Group N.V., and Ossur Group.

Market Segmentation & Coverage

This research report categorizes the Spinal Devices & Biologics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Fracture Treatment, Motion Preservation, Non-Fusion Technologies, and Spinal Fusion & Fixation.
  • Based on Application, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of degenerative spine disorders
      • 5.1.1.2. Surging demand for minimally invasive spine surgery
      • 5.1.1.3. Growing technological advancements in spine biologics
    • 5.1.2. Restraints
      • 5.1.2.1. Issues related to product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising demand for spinal implants and devices
      • 5.1.3.2. Improvement in augmented & virtual reality, endoscopic surgery, and 3D printed implants for spine surgery
    • 5.1.4. Challenges
      • 5.1.4.1. Unfavorable and ambiguity in reimbursement policies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Spinal Devices & Biologics Market, by Type

  • 6.1. Introduction
  • 6.2. Fracture Treatment
  • 6.3. Motion Preservation
  • 6.4. Non-Fusion Technologies
  • 6.5. Spinal Fusion & Fixation

7. Spinal Devices & Biologics Market, by Application

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Clinics
  • 7.4. Hospitals

8. Americas Spinal Devices & Biologics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Spinal Devices & Biologics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Spinal Devices & Biologics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acuity Surgical Devices, LLC
  • 2. Aesculap Implant Systems, LLC
  • 3. DJO, LLC
  • 4. Exactech, Inc.
  • 5. Innovasis, Inc.
  • 6. Integra LifeSciences Holdings Corporation
  • 7. Invictus Medical LLC
  • 8. Kohlberg & Company, LLC
  • 9. Medtronic PLC
  • 10. NuVasive, Inc.
  • 11. Orthofix Medical Inc.
  • 12. Smith & Nephew PLC
  • 13. Stryker Corporation
  • 14. Wright Medical Group N.V.
  • 15. Ossur Group

LIST OF FIGURES

  • FIGURE 1. SPINAL DEVICES & BIOLOGICS MARKET RESEARCH PROCESS
  • FIGURE 2. SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. SPINAL DEVICES & BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. SPINAL DEVICES & BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SPINAL DEVICES & BIOLOGICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SPINAL DEVICES & BIOLOGICS MARKET DYNAMICS
  • TABLE 7. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY FRACTURE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY MOTION PRESERVATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY NON-FUSION TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY SPINAL FUSION & FIXATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM SPINAL DEVICES & BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SPINAL DEVICES & BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. SPINAL DEVICES & BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023